Terms: = Endocrine gland cancer AND ER, estrogen receptor
2009 results:
1. Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer.
Liu X; Ren B; Fang Y; Ren J; Wang X; Gu M; Zhou F; Xiao R; Luo X; You L; Zhao Y
J Transl Med; 2024 Apr; 22(1):393. PubMed ID: 38685045
[TBL] [Abstract] [Full Text] [Related]
2. ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC.
Böpple K; Oren Y; Henry WS; Dong M; Weller S; Thiel J; Kleih M; Gaißler A; Zipperer D; Kopp HG; Aylon Y; Oren M; Essmann F; Liang C; Aulitzky WE
Cell Death Dis; 2024 Apr; 15(4):290. PubMed ID: 38658567
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian cancer.
Torres-Esquius S; Llop-Guevara A; Gutiérrez-Enríquez S; Romey M; Teulé À; Llort G; Herrero A; Sánchez-Henarejos P; Vallmajó A; González-Santiago S; Chirivella I; Cano JM; Graña B; Simonetti S; Díaz de Corcuera I; Ramon Y Cajal T; Sanz J; Serrano S; Otero A; Churruca C; Sánchez-Heras AB; Servitja S; Guillén-Ponce C; Brunet J; Denkert C; Serra V; Balmaña J
JAMA Netw Open; 2024 Apr; 7(4):e247811. PubMed ID: 38648056
[TBL] [Abstract] [Full Text] [Related]
4. Spectrally separated dual-label upconversion luminescence lateral flow assay for cancer-specific STn-glycosylation in CA125 and CA15-3.
Ekman M; Salminen T; Raiko K; Soukka T; Gidwani K; Martiskainen I
Anal Bioanal Chem; 2024 May; 416(13):3251-3260. PubMed ID: 38584178
[TBL] [Abstract] [Full Text] [Related]
5. Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells.
Lee J; Jang S; Im J; Han Y; Kim S; Jo H; Wang W; Cho U; Kim SI; Seol A; Kim B; Song YS
J Ovarian Res; 2024 Apr; 17(1):73. PubMed ID: 38566208
[TBL] [Abstract] [Full Text] [Related]
6. Effect of Risk Factor Score on Early Recurrence After Pancreatectomy for Invasive Pancreatic Ductal Adenocarcinoma.
Matsumoto M; Shirai Y; Abe K; Futagawa Y; Haruki K; Furukawa K; Onda S; Hamura R; Tanji Y; Tsunematsu M; Shiozaki H; Okamoto T; Ikegami T
Anticancer Res; 2024 Apr; 44(4):1695-1702. PubMed ID: 38537987
[TBL] [Abstract] [Full Text] [Related]
7. Nomogram model for predicting early recurrence for resectable pancreatic cancer: A multicenter study.
Man Q; Pang H; Liang Y; Chang S; Wang J; Gao S
Medicine (Baltimore); 2024 Mar; 103(10):e37440. PubMed ID: 38457597
[TBL] [Abstract] [Full Text] [Related]
8. A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial.
Ottenbourgs T; van Gorp T; Kridelka F; Baert T; Denys H; Selle F; Baas I; Van Rompuy AS; Lambrechts D; Van Nieuwenhuysen E
Int J Gynecol Cancer; 2024 Apr; 34(4):627-630. PubMed ID: 38453176
[TBL] [Abstract] [Full Text] [Related]
9. Mesonephric-like adenocarcinoma of the ovary.
Yang Y; Zhao M; Jia Q; Tang H; Xing T; Li Y; Tang B; Xu L; Wei W; Zheng H; Shi R; Xia B; Chen J
J Ovarian Res; 2024 Mar; 17(1):57. PubMed ID: 38444000
[TBL] [Abstract] [Full Text] [Related]
10. A novel CSN5/CRT O-GlcNAc/ER stress regulatory axis in platinum resistance of epithelial ovarian cancer.
Yan T; Ma X; Zhou K; Cao J; Tian Y; Zheng H; Tong Y; Xie S; Wang Y; Guo L; Lu R
Int J Biol Sci; 2024; 20(4):1279-1296. PubMed ID: 38385070
[No Abstract] [Full Text] [Related]
11. Identification of myoferlin as a mitochondria-associated membranes component required for calcium signaling in PDAC cell lines.
Anania S; Farnir M; Peiffer R; Boumahd Y; Thiry M; Agirman F; Maloujahmoum N; Bellahcène A; Peulen O
Cell Commun Signal; 2024 Feb; 22(1):133. PubMed ID: 38368370
[TBL] [Abstract] [Full Text] [Related]
12. Unfolded Protein-Based Sandwich AIE Probe Imparts High Fluorescent Contrast for Pan-cancer Surgical Navigation.
Wang Q; Chen B; Duan C; Wang T; Lou X; Dai J; Xia F
Anal Chem; 2024 Feb; 96(8):3609-3617. PubMed ID: 38364862
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
[TBL] [Abstract] [Full Text] [Related]
14. AURKA Enhances the Glycolysis and Development of Ovarian Endometriosis Through ERβ.
Sun Y; Zhang S; Zhang X; Li G; Sun F; Wang M; Ren C; Jiang A; Yang T
Endocrinology; 2024 Feb; 165(4):. PubMed ID: 38340326
[TBL] [Abstract] [Full Text] [Related]
15. Machine learning-assisted high-content imaging analysis of 3D MCF7 microtissues for estrogenic effect prediction.
Li H; Seada H; Madnick S; Zhao H; Chen Z; Li F; Zhu F; Hall S; Boekelheide K
Sci Rep; 2024 Feb; 14(1):2999. PubMed ID: 38316851
[TBL] [Abstract] [Full Text] [Related]
16. Effects of postoperative antioxidants on the salivary glands in patients with thyroid cancer undergoing radioactive iodine-131 treatment.
Tong H; Yue R; Fang J; Li X; Yang S; Hou Y; Wang R; Zhang B; Liu H; Wu Z; Cheng Y
Nucl Med Commun; 2024 Apr; 45(4):312-320. PubMed ID: 38312062
[TBL] [Abstract] [Full Text] [Related]
17. The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review.
Lin J; Liu L; Wang L; Ma N; Zhang K; Xie N; Yu H; Deng S; Sun Y
World J Surg Oncol; 2024 Feb; 22(1):42. PubMed ID: 38310233
[TBL] [Abstract] [Full Text] [Related]
18. Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect.
Li X; Zheng H; Ma C; Ji Y; Wang X; Sun D; Meng Z; Zheng W
Front Endocrinol (Lausanne); 2023; 14():1307325. PubMed ID: 38298190
[TBL] [Abstract] [Full Text] [Related]
19. Profiling of Unfolded Protein Response Markers and Effect of IRE1α-specific Inhibitor in Pituitary Neuroendocrine Tumor.
Morita S; Uraki S; Ariyasu H; Tsuji T; Doi A; Furuta H; Yamoto T; Nakao N; Akamizu T; Matsuoka TA
Endocrinology; 2024 Feb; 165(4):. PubMed ID: 38289718
[TBL] [Abstract] [Full Text] [Related]
20. Impact factors of benefiting from initial 131 I ablation in patients with intermediate-risk differentiated thyroid carcinoma: a study based on a re-evaluation of therapeutic response.
Ren L; Hu Y; Hu Y; Xiao D; Sun J; Zhu B; Zhang C
Nucl Med Commun; 2024 Mar; 45(3):188-195. PubMed ID: 38165164
[TBL] [Abstract] [Full Text] [Related]
[Next]
